Robert Garland

Who is Robert Garland?

Robert joined NEA in December 2003 as a Principal and became a Partner in 2007. He invests in biopharmaceuticals and medical devices. Robert is a director of Cardioxyl Pharmaceuticals. Prior to NEA, in addition to clinical practice, he was with McKinsey Company's Pharmaceutical Medical Products and Corporate Finance Strategy practices. At McKinsey, Robert worked with biotech, pharmaceutical, medical device, diagnostics, and private equity clients to evaluate investments, formulate product and corporate strategies and build businesses. Robert completed his Residency in Internal Medicine and Fellowship in Infectious Diseases at the University of California, San Francisco. He received his MBA and MPH from the University of California, Berkeley, his MD from Baylor College of Medicine, and his BSEE from Rice University.